Bcr-Abl Hyper-Activation Causes Cell Death through Metabolic Changes
Author Information
Author(s): Dengler Michael A., Staiger Annette M., Gutekunst Matthias, Hofmann Ute, Doszczak Malgorzata, Scheurich Peter, Schwab Matthias, Aulitzky Walter E., van der Kuip Heiko
Primary Institution: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen
Hypothesis
How does hyper-activation of Bcr-Abl lead to cell death in leukemia cells?
Conclusion
Excessive metabolic changes induced by Bcr-Abl hyper-activation are key mediators of cell death.
Supporting Evidence
- Imatinib withdrawal led to rapid induction of Bcr-Abl activity.
- Cell death was preceded by enhanced glycolysis and amino acid metabolism.
- Inhibition of glycolysis or glutaminolysis sustained cell viability.
- Corticosteroids normalized cellular metabolism and prevented cell death.
- Cell death was dependent on p38 and RIP1 signaling pathways.
- ER stress markers were induced upon imatinib withdrawal.
- High rates of glucose utilization were linked to cell death.
Takeaway
When certain cancer cells are stressed, they can die from too much energy production, which is like a car running out of control.
Methodology
The study used Bcr-Abl over-expressing cells and analyzed their response to imatinib withdrawal, measuring metabolic changes and cell death.
Potential Biases
Potential bias in drug screening results due to the limited number of tested compounds.
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Participant Demographics
The study involved Bcr-Abl over-expressing cell lines, not human participants.
Statistical Information
P-Value
0.0048
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website